All News

Although the number of dispensed opioid prescriptions has somewhat declined, overdose deaths involving opioids continue to rise. The FDA is requiring stronger warnings of risk.

Your daily dose of clinical news you may have missed.

Four months of meditation improved quality of life and psychological symptoms in patients with CAD, according to research presented at ESC Preventive Cardiology 2023.

To be marketed as Rizafilm, the product is a disintegrating film formulation of the 5-HT-1 receptor antagonist and proven bioequivalent to Merck's Maxalt-MLT.

Chronic and chronic high-impact pain disproportionately affect AI/AN populations, gay and lesbian adults, and separated or divorced individuals, according to new data.

The shapes, sizes, and content of a US alcoholic drink-equivalent vary widely. Get a quick educational summary of the variety and more data that may help in your daily clinical practice.

Clopidogrel bests aspirin for post-PCI monotherapy; metabolic dysfunction predicts HCC in post-HCV fibrosis; brain signatures may help focus obesity treatment for the sexes, and 2 more studies of note.

Results showed that on average, personalized treatment choice had the potential to provide an additional 4.4 mm Hg-lower systolic blood pressure.

Your daily dose of clinical news you may have missed.

The $462 million monetary penalty is accompanied “the most stringent restrictions” on how the company markets, sells, and distributes its products.

Your daily dose of clinical news you may have missed.

Metabolomic signatures identified in red and processed meat are associated with an increased risk of IHD, according to new findings.

Migraine disproportionately affects women, a disparity typically ascribed to hormonal differences. A new study takes a new look at the issue.

Among other improvements, bariatric surgery may help reverse peripheral neuropathy and stabilize cardiovascular autonomic neuropathy, according to new findings.

Your daily dose of clinical news you may have missed.

A population-based study found metabolic dysfunction more prevalent than ultrasonographic steatosis in patients recovered from HCV and a better predictive tool for disease progression.

Your daily dose of clinical news you may have missed.